Discover the latest tools and techniques with expert-led presentations on integrating AI into live-cell image analysis workflows, viral respiratory infections in the pediatric population, miniaturized high-throughput transcriptomics for preclinical drug discovery, and much more
Over a billion Eppis have been sold worldwide since its introduction in 1963
Revolutionizing safe and efficient photochemical flow synthesis
Explore the latest developments in biopharma with fellow scientists, manufacturers, and regulatory experts
Explore innovations such as oligonucleotide therapeutics, bi-specific antibodies, CAR-T therapy and CRISPR
QCI Interpret selected to support Denmark's whole-genome sequencing program
University of Groningen's iGEM 2022 project utilizes VIAFLO pipettes to combat H5N1 transmission
Liquid handling solutions for flexible molecular diagnostics workflows
Discover how digital laboratory tools provider eLabNext is teaming up with artificial intelligence (AI) software companies to create new, integrated AI laboratory solutions
Good documentation of lab processes and equipment is essential for safe and efficient projects
Uncover the remarkable evolution of point-of-care diagnostics as we examine the significant breakthroughs achieved over the years and explore exciting future directions
Explore the versatile role of ddPCR technology in immuno-oncology for precise and sensitive nucleic acid quantification
Exhibit to include rapid tests, RT-PCR tests (based on molecular biology), chemiluminescence (CLIA), and turbidimetry, in addition to raw materials for diagnostic product manufacturers
Labs seek guidance in reducing their environmental footprint by increasing efficiency but overall convey optimism on sustainability efforts
Maximizing the benefits of cloud deployment through HALO expertise
The Intabio ZT system is the first available system to fully integrate icIEF-UV and mass spectrometry
Introducing BioXplorer 400XL and BioXplorer 400P for efficient and cost-effective bioprocess optimization
Explore the importance of robust and reliable cell-based assays in the development of therapeutic bispecific antibodies in immuno-oncology
